Serum beta2-microglobulin levels in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy: relationship with virological breakthrough.

Ioannis S. Elefsiniotis,Nikolaos Scarmeas,Irene Glynou,Konstantinos D. Pantazis,Helen Kada,Christos Mavrogiannis

Serum beta2-microglobulin levels in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy: relationship with virological breakthrough.

2004

Ioannis S. Elefsiniotis
Nikolaos Scarmeas
Irene Glynou
Konstantinos D. Pantazis
Helen Kada
Christos Mavrogiannis

OBJECTIVES: To evaluate the predictive value of serum beta2-microglobulin (β2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.

Keywords:

Hepatitis B
General surgery
Gastroenterology
Beta-2 microglobulin
Hepatitis b e antigen negative
Lamivudine
Diabetes mellitus
Medicine
Internal medicine
predictive value
chronic hepatitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations